iss057e106231 (Nov. 26, 2018) --- European Space Agency (ESA) asrtonaut Alexander Gerst uses a uses a pipette to transfer a protein solution into the Protein Crystal Growth Card for an experiment observing protein crystals associated with Parkinson’s disease to potentially improve treatments on Earth. Crystallization of LRRK2 Under Microgravity Conditions-2 (CASIS PCG 16) evaluates growth of Leucine-rich repeat kinase 2 (LRRK2) protein crystals in microgravity. LRRK2 is implicated in Parkinson’s disease, but crystals of the protein grown on Earth are too small and compact to study. Detailed analysis of larger, space-grown crystals can define the protein’s exact shape and morphology and help scientists better understand the disease’s pathology.